Comparing the effects of different sodium-glucose link transporter 2 inhibitors (SGLT2i) on HbA1c and weight in the real world: Updated analysis from the Association of British Clinical Diabetologists (ABCD) audit programmes

被引：0
|
作者：
Crabtree, T. S. J. [1 ,2 ,3 ]
Dhatariya, K. [4 ]
Bickerton, A. [5 ]
Sivappriyan, S. [6 ]
Barnes, D. [6 ]
Tarpey, S. [7 ]
Rowles, S. [7 ]
Adamson, K. [8 ]
Gallen, I. [9 ]
Ryder, R. E. J. [1 ]
机构：
[1] Sandwell & West Birmingham Hosp NHS Trust, City Hosp, Dept Diabet & Endocrinol, Birmingham, W Midlands, England
[2] Univ Hosp Derby & Burton NHS Trust, Royal Derby Hosp, Dept Diabet & Endocrinol, Derby, England
[3] Univ Nottingham, Royal Derby Hosp, Sch Med, Derby, England
[4] Norfolk & Norwich Univ Hosp NHS Trust, Dept Diabet & Endocrinol, Norwich, Norfolk, England
[5] Yeovil Dist Hosp NHS FT, Dept Diabet & Endocrinol, Yeovil, England
[6] Maidstone & Tunbridge Wells Hosp NHS Trust, Dept Diabet, Maidstone, Kent, England
[7] Pennine Acute Hosp NHS Trust, Dept Diabet & Endocrinol, Manchester, Lancs, England
[8] St Johns Hosp, Dept Diabet & Endocrinol, Livingston, Scotland
[9] Royal Berkshire Hosp NHS Trust, Dept Diabet, Reading, Berks, England
来源：
DIABETIC MEDICINE | 2021年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A20 (P245)
引用
收藏
页数：3
相关论文
共 23 条
  • [1] Predictors of HbA1c and Weight Response to Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in the Association of British Clinical Diabetologist (ABCD) UK Nationwide Audit
    Crabtree, Thomas S. J.
    Gallagher, Alison
    Sivappriyan, Siva
    Dhatariya, Ketan
    Raghavan, Rajeev P.
    Bickerton, Alex
    Elliott, Jackie
    Cull, Melissa L.
    Rayman, Gerry
    Gallen, Ian W.
    Idris, Iskandar R.
    Ryder, Robert E.
    DIABETES, 2022, 71
  • [2] The effect of sodium-glucose link transporter 2 inhibitors (SGLT2i) on microalbuminuria: Cross-class analysis from the ABCD audit programme
    Crabtree, T. S. J.
    Gallagher, A.
    Gallen, I.
    Melvin, A.
    Elliott, J.
    Bickerton, A.
    Dhatariya, K.
    Rayman, G.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2022, 39
  • [3] Effect of Raised Alanine Transaminase (ALT) Levels on HbA1c in the Association of British Clinical Diabetologists (ABCD) Nationwide Audits of SGLT2 Inhibitors (SGLT2i)
    Deshmukh, Harshal
    Bickerton, Alex
    Phillips, Suzanne M.
    Evans, Alison
    Raghavan, Rajeev P.
    Sennik, Devesh K.
    Rohilla, Anurita
    Adamson, Karen
    Yadagiri, Mahender
    Gallen, Ian W.
    Ryder, Robert E.
    Sathyapalan, Thozhukat
    DIABETES, 2020, 69
  • [4] The impact of sodium glucose link transporter-2 inhibitors (SGLT2i) on Fib4 score in patients with type 2 diabetes: Analysis using Association of British Clinical Diabetologists (ABCD) nationwide audit data
    Crabtree, T. S. J.
    Elliott, J.
    Sivappriyan, S.
    Barnes, D.
    Bickerton, A.
    Gallen, I.
    Idris, I.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2021, 38
  • [5] Effect of IDegLira on HbA1c and Weight: Data from the Association of British Clinical Diabetologists (ABCD) IDegLira Audit
    Noronha, Sean
    Lumb, Alistair N.
    Bickerton, Alex
    Sim, Sing Yee
    Gallen, Ian W.
    Adamson, Karen
    Ryder, Robert E.
    DIABETES, 2019, 68
  • [6] Predictors of HbA1c and weight response to semaglutide: Results from the Association of British Clinical Diabetologists (ABCD) audit programme
    Crabtree, T. S. J.
    Adamson, K.
    Reid, H.
    Barnes, D.
    Sivappriyan, S.
    Bickerton, A.
    Gallen, I. W.
    Gallagher, A.
    Idris, I.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2022, 39
  • [7] Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in type 1 diabetes
    Dashora, Umesh
    Patel, Dipesh
    Gregory, Rob
    Nagi, Dinesh
    BRITISH JOURNAL OF DIABETES, 2018, 18 (03): : 117 - 121
  • [8] Sodium-glucose link transporter-2 inhibitors in reduced renal function: cross-class comparison from the Association of British Clinical Diabetologists (ABCD) audits
    Crabtree, T. S. J.
    Bickerton, A.
    Dhatariya, K.
    Gallagher, A.
    Elliott, J.
    Raghavan, R.
    Gallen, I. W.
    Ryder, R. E. J.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S280 - S280
  • [9] Sodium-glucose linked transporter 2 inhibitors (SGLT2s) and alanine aminotransferase levels (ALT) in the Associated of British Clinical Diabetologists (ABCD) audits
    Gallen, I.
    Crabtree, T. S. J.
    Gallagher, A.
    Dhatariya, K.
    Bickerton, A.
    Elliott, J.
    Rayman, G.
    Ryder, R. E. J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 218 - 218
  • [10] Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019)
    Dashora, Umesh
    Patel, Dipesh C.
    Gregory, Robert
    Winocour, Peter
    Dhatariya, Ketan
    Nagi, Dinesh
    BRITISH JOURNAL OF DIABETES, 2019, 19 (01): : 66 - 72
123